Going to 11: New Subsections at CDER’s Office of Pharmaceutical Quality Are Important Piece of FDA’s Inspection and Enforcement Strategy
FDA Law Blog
NOVEMBER 20, 2023
Claud — The word last week was that FDA is re-organizing the Office of Pharmaceutical Quality (OPQ) within the Center for Drug Evaluation and Research (CDER). The Agency wants to see functional, effective cultures of quality, and expects that C-suites will provide support to quality units. By John W.M.
Let's personalize your content